Investor Overview

Stock Price

NASDAQ TCMD (Common Stock) $25.98 - 0.23
November 17, 20174:00 p.m. ET
Data provided by Nasdaq. Minimum 15 minutes delayed.

Investor Presentation

Download Documentation Q3 2017 Investor Presentation

Annual Reports

Download Documentation 2016 Annual Report to Stockholders

Company Overview

Tactile Medical is a leader in treatment options for lymphedema and venous ulcer therapies. Tactile Medical develops advanced home therapy devices to improve health and quality of life for patients with chronic swelling conditions. Headquartered in Minneapolis, Minnesota, we advocate for patient access and serve tens of thousands of patients through a national network of product specialists and trainers, reimbursement experts, patient advocates, and clinical staff. Our products are proven to improve quality of life, increase clinical efficacy, and reduce overall healthcare costs.

Recent News

Tactile Medical to Participate in the 29th Annual Piper Jaffray Healthcare Conference

November 16, 2017

MINNEAPOLIS, Nov. 16, 2017 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”... 

Read More >

Tactile Systems Technology, Inc. Reports Third Quarter 2017 Financial Results; Updates 2017 Outlook

November 7, 2017

Q3 Revenue Increase of 25% Year-over-Year; Revenue Up 33% Year-to-Date MINNEAPOLIS, Nov. 07, 2017 ... 

Read More >

Upcoming Events

Tactile Systems Technology, Inc. at 29th Annual Piper Jaffray Healthcare Conference
Tuesday, November 28, 2017 9:00 a.m. ET
Print Page Print Page | E-mail Page E-mail Page | RSS Feeds RSS Feeds | E-mail Alerts E-mail Alerts | IR Contacts Investor Contacts | Financial Tear Sheet Financial Tear Sheet